{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:54:30Z","timestamp":1792742070814,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["25ZXZSSS00260"],"award-info":[{"award-number":["25ZXZSSS00260"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04263-y","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:17:20Z","timestamp":1773832640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prussian blue analogue-mineralized ginseng-derived vesicles promote PPAR\u03b3 nuclear translocation to suppress tumor vasculogenic mimicry and reverse the immunosuppressive microenvironment"],"prefix":"10.1186","volume":"24","author":[{"given":"Chaoqin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxia","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"3","key":"4263_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN Estimates of Incidence and mortality worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4263_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42(3):629\u201352.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"4263_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","volume":"79","author":"AD Ladd","year":"2024","unstructured":"Ladd AD, Duarte S, Sahin I, Zarrinpar A. Mechanisms of drug resistance in HCC. Hepatology. 2024;79(4):926\u201340.","journal-title":"Hepatology"},{"issue":"3","key":"4263_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","volume":"91","author":"S Goel","year":"2011","unstructured":"Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011;91(3):1071\u2013121.","journal-title":"Physiol Rev"},{"issue":"1","key":"4263_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","volume":"39","author":"X Jiang","year":"2020","unstructured":"Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, et al. The role of microenvironment in tumor angiogenesis. J Exp Clin Cancer Res. 2020;39(1):204.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4263_CR6","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/s41467-023-36910-5","volume":"14","author":"CJ LaFargue","year":"2023","unstructured":"LaFargue CJ, Amero P, Noh K, Mangala LS, Wen Y, Bayraktar E, et al. Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L. Nat Commun. 2023;14(1):2407.","journal-title":"Nat Commun"},{"issue":"1","key":"4263_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40265-018-1037-9","volume":"79","author":"A Lopez","year":"2019","unstructured":"Lopez A, Harada K, Vasilakopoulou M, Shanbhag N, Ajani JA. Targeting angiogenesis in colorectal carcinoma. Drugs. 2019;79(1):63\u201374.","journal-title":"Drugs"},{"issue":"1","key":"4263_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12943-020-01288-1","volume":"20","author":"X Wei","year":"2021","unstructured":"Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, et al. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021;20(1):7.","journal-title":"Mol Cancer"},{"issue":"1","key":"4263_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-00858-6","volume":"13","author":"Q Luo","year":"2020","unstructured":"Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, et al. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol. 2020;13(1):19.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"4263_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10555-022-10067-x","volume":"41","author":"E Andreucci","year":"2022","unstructured":"Andreucci E, Peppicelli S, Ruzzolini J, Bianchini F, Calorini L. Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry. Cancer Metastasis Rev. 2022;41(4):935\u201351.","journal-title":"Cancer Metastasis Rev"},{"issue":"24","key":"4263_CR11","doi-asserted-by":"publisher","first-page":"e2419540","DOI":"10.1002\/adma.202419540","volume":"37","author":"S Zheng","year":"2025","unstructured":"Zheng S, Zhang X, Yang F, Chang Z, Han J, Zhang H, et al. Glycated ECM derived carbon dots inhibit tumor vasculogenic mimicry by disrupting RAGE nuclear translocation and its interaction with HMGB1. Adv Mater (Deerfield Beach, Fla). 2025;37(24):e2419540.","journal-title":"Adv Mater (Deerfield Beach, Fla.)"},{"issue":"1","key":"4263_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12964-024-01605-x","volume":"22","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Zhang X, Lu F, Miao S, Zhang C, Liu Z, et al. RUNX1-BMP2 promotes vasculogenic mimicry in laryngeal squamous cell carcinoma via activation of the PI3K-AKT signaling pathway. Cell Commun Signal. 2024;22(1):227.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"4263_CR13","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1016\/j.apsb.2024.09.005","volume":"14","author":"A Zhao","year":"2024","unstructured":"Zhao A, Zhou C, Li J, Wang Z, Zhu H, Shen S, et al. UBE2G2 inhibits vasculogenic mimicry and metastasis of uveal melanoma by promoting ubiquitination of LGALS3BP. Acta Pharm Sin B. 2024;14(12):5201\u201318.","journal-title":"Acta Pharm Sin B"},{"key":"4263_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109116","volume":"111","author":"H Hu","year":"2022","unstructured":"Hu H, Ma T, Liu N, Hong H, Yu L, Lyu D, et al. Immunotherapy checkpoints in ovarian cancer vasculogenic mimicry: tumor immune microenvironments, and drugs. Int Immunopharmacol. 2022;111:109116.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"4263_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","volume":"26","author":"AC Dudley","year":"2023","unstructured":"Dudley AC, Griffioen AW. Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis. 2023;26(3):313\u201347.","journal-title":"Angiogenesis"},{"key":"4263_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.actbio.2023.12.047","volume":"176","author":"P Wang","year":"2024","unstructured":"Wang P, Sun S, Bai G, Zhang R, Liang F, Zhang Y. Nanosized Prussian blue and its analogs for bioimaging and cancer theranostics. Acta Biomater. 2024;176:77\u201398.","journal-title":"Acta Biomater"},{"key":"4263_CR17","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.2147\/IJN.S475973","volume":"19","author":"L Xu","year":"2024","unstructured":"Xu L, Liu J, Li S, Lu X, Gu W, Zhu S, et al. S-doped hollow multi-metallic Prussian blue analogue (PBA) nanoplatform for enhanced anticancer for cervical cancer. Int J Nanomedicine. 2024;19:8681\u201394.","journal-title":"Int J Nanomedicine"},{"key":"4263_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114834","volume":"254","author":"S Zhu","year":"2025","unstructured":"Zhu S, Ning Y, Zhang M, Wei F, Li S, Wang M, et al. Pd, S co-modified Prussian blue analogues nanocomposites for MRI guided combined mitochondria-targeting cancer therapy with tumor microenvironment remodeling, multienzyme-like catalysis and mild photothermal therapeutic effect, Colloids and surfaces. B Biointerfaces. 2025;254:114834.","journal-title":"B Biointerfaces"},{"key":"4263_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108391","volume":"245","author":"H Chen","year":"2023","unstructured":"Chen H, Tan H, Wan J, Zeng Y, Wang J, Wang H, et al. PPAR-\u03b3 signaling in nonalcoholic fatty liver disease: pathogenesis and therapeutic targets. Pharmacol Ther. 2023;245:108391.","journal-title":"Pharmacol Ther"},{"key":"4263_CR20","doi-asserted-by":"publisher","first-page":"156097","DOI":"10.1016\/j.metabol.2024.156097","volume":"163","author":"F Chen","year":"2025","unstructured":"Chen F, Ma L, Liu Q, Zhou Z, Yi W. Recent advances and therapeutic applications of PPAR\u03b3-targeted ligands based on the inhibition mechanism of Ser273 phosphorylation. Metab Clin Exp. 2025;163:156097.","journal-title":"Metab Clin Exp"},{"issue":"11","key":"4263_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41419-023-06283-0","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Ji S, Xie X, Si L, Liu S, Lin Y, et al. Deciphering the interaction between Twist1 and PPAR\u03b3 during adipocyte differentiation. Cell Death Dis. 2023;14(11):764.","journal-title":"Cell Death Dis"},{"key":"4263_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106786","volume":"192","author":"YY Qiu","year":"2023","unstructured":"Qiu YY, Zhang J, Zeng FY, Zhu YZ. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Pharmacol Res. 2023;192:106786.","journal-title":"Pharmacol Res"},{"key":"4263_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.624112","volume":"12","author":"M Hernandez-Quiles","year":"2021","unstructured":"Hernandez-Quiles M, Broekema MF, Kalkhoven E. PPARgamma in Metabolism Immunity, and Cancer: Unified and Diverse Mechanisms of Action. Front Endocrinol. 2021;12:624112.","journal-title":"Front Endocrinol"},{"key":"4263_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155116","volume":"121","author":"J Liang","year":"2023","unstructured":"Liang J, Yang C, Li P, Zhang M, Xie X, Xie X, et al. Astragaloside IV inhibits AOM\/DSS-induced colitis-associated tumorigenesis via activation of PPAR\u03b3 signaling in mice. Phytomedicine. 2023;121:155116.","journal-title":"Phytomedicine"},{"issue":"1","key":"4263_CR25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.7150\/thno.90322","volume":"14","author":"LN Qin","year":"2024","unstructured":"Qin LN, Zhang H, Li QQ, Wu T, Cheng SB, Wang KW, et al. Vitamin D binding protein (VDBP) hijacks twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma. Theranostics. 2024;14(1):436\u201350.","journal-title":"Theranostics"},{"issue":"1","key":"4263_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12951-023-01835-0","volume":"21","author":"J Liu","year":"2023","unstructured":"Liu J, Xiang J, Jin C, Ye L, Wang L, Gao Y, et al. Medicinal plant-derived mtDNA via nanovesicles induces the cGAS-STING pathway to remold tumor-associated macrophages for tumor regression. J Nanobiotechnol. 2023;21(1):78.","journal-title":"J Nanobiotechnol"},{"key":"4263_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106721","author":"Z Li","year":"2023","unstructured":"Li Z, Zhang H, Sun Y, Feng Z, Cui B, Han J, et al. Live-cell imaging-based dynamic vascular formation assay for antivascular drug evaluation and screening. iScience. 2023. https:\/\/doi.org\/10.1016\/j.isci.2023.106721.","journal-title":"iScience"},{"key":"4263_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105507","volume":"166","author":"N Zheng","year":"2021","unstructured":"Zheng N, Zhang S, Wu W, Zhang N, Wang J. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma. Pharmacol Res. 2021;166:105507.","journal-title":"Pharmacol Res"},{"issue":"1","key":"4263_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209990120","volume":"120","author":"LQ Zhou","year":"2023","unstructured":"Zhou LQ, Dong MH, Hu ZW, Tang Y, Chu YH, Chen M, et al. Staged suppression of microglial autophagy facilitates regeneration in CNS demyelination by enhancing the production of linoleic acid. Proc Natl Acad Sci U S A. 2023;120(1):e2209990120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"4263_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cmet.2023.03.005","volume":"35","author":"X Liu","year":"2023","unstructured":"Liu X, Gu Y, Kumar S, Amin S, Guo Q, Wang J, et al. Oxylipin-PPAR\u03b3-initiated adipocyte senescence propagates secondary senescence in the bone marrow. Cell Metab. 2023;35(4):667\u201384.","journal-title":"Cell Metab"},{"key":"4263_CR31","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.2147\/DDDT.S524893","volume":"19","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Jin R, Gu Y, Ji Y, Lou Y, Wu J. Therapeutic Targeting of PPAR\u03b3 in Nonalcoholic Fatty Liver Disease: Efficacy Safety, and Drug Development. Drug Des Devel Ther. 2025;19:7293\u2013319.","journal-title":"Drug Des Devel Ther"},{"key":"4263_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113887","volume":"176","author":"M Zu","year":"2021","unstructured":"Zu M, Ma Y, Cannup B, Xie D, Jung Y, Zhang J, et al. Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases. Adv Drug Deliv Rev. 2021;176:113887.","journal-title":"Adv Drug Deliv Rev"},{"issue":"38","key":"4263_CR33","doi-asserted-by":"publisher","first-page":"E5618","DOI":"10.1073\/pnas.1608384113","volume":"113","author":"K Hosaka","year":"2016","unstructured":"Hosaka K, Yang Y, Seki T, Fischer C, Dubey O, Fredlund E, et al. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci U S A. 2016;113(38):E5618\u201327.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"761","key":"4263_CR34","doi-asserted-by":"publisher","first-page":"0904","DOI":"10.1126\/scitranslmed.adn0904","volume":"16","author":"Z Lu","year":"2024","unstructured":"Lu Z, Verginadis I, Kumazoe M, Castillo GM, Yao Y, Guerra RE, et al. Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapies. Sci Transl Med. 2024;16(761):0904.","journal-title":"Sci Transl Med"},{"issue":"19","key":"4263_CR35","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1158\/0008-5472.CAN-24-4323","volume":"85","author":"K Chen","year":"2025","unstructured":"Chen K, Feng H, Zhang Y, Pei J, Xu Y, Wei X, et al. Tumor-derived CCL16 normalizes tumor vasculature through macrophage ICAM-1 receptor and enhances immunotherapy efficacy in hepatocellular carcinoma. Cancer Res. 2025;85(19):3633\u201350.","journal-title":"Cancer Res"},{"issue":"1","key":"4263_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ymthe.2021.08.028","volume":"30","author":"X Han","year":"2022","unstructured":"Han X, Wei Q, Lv Y, Weng L, Huang H, Wei Q, et al. Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. Mol Ther. 2022;30(1):327\u201340.","journal-title":"Mol Ther"},{"issue":"1","key":"4263_CR37","first-page":"56","volume":"30","author":"X Liu","year":"2024","unstructured":"Liu X, Li J, Huang Q, Jin M, Huang G. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-\u03b1\/PDK4 axis in non-small cell lung cancer. Mol Med (Cambridge, Mass). 2024;30(1):56.","journal-title":"Mol Med (Cambridge, Mass.)"},{"issue":"1","key":"4263_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41538-024-00341-3","volume":"8","author":"S Liu","year":"2024","unstructured":"Liu S, Ai Z, Hu Y, Ren G, Zhang J, Tang P, et al. Ginseng glucosyl oleanolate inhibit cervical cancer cell proliferation and angiogenesis via PI3K\/AKT\/HIF-1\u03b1 pathway. NPJ Science Food. 2024;8(1):105.","journal-title":"NPJ Science Food"},{"key":"4263_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106988","volume":"198","author":"MY Huang","year":"2023","unstructured":"Huang MY, Chen YC, Lyu WY, He XY, Ye ZH, Huang CY, et al. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8(+) T cells via increasing intratumoral CXCL10. Pharmacol Res. 2023;198:106988.","journal-title":"Pharmacol Res"},{"issue":"14","key":"4263_CR40","doi-asserted-by":"publisher","first-page":"e2206848","DOI":"10.1002\/smll.202206848","volume":"19","author":"R Wang","year":"2023","unstructured":"Wang R, Qian C, Zhang Z, Shen H, Xia J, Cui D, et al. Advance of Prussian Blue-Derived Nanohybrids in Energy Storage: Current Status and Perspective. Small. 2023;19(14):e2206848.","journal-title":"Small"},{"issue":"9","key":"4263_CR41","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/s41423-025-01323-5","volume":"22","author":"W Wang","year":"2025","unstructured":"Wang W, Qiao S, Kong X, Zhang G, Cai Z. The role of exosomes in immunopathology and potential therapeutic implications. Cell Mol Immunol. 2025;22(9):975\u201395.","journal-title":"Cell Mol Immunol"},{"issue":"36","key":"4263_CR42","doi-asserted-by":"publisher","first-page":"19766","DOI":"10.1021\/acs.jafc.4c02824","volume":"72","author":"Y Chen","year":"2024","unstructured":"Chen Y, Ma W, Zhao J, Stanton C, Ross RP, Zhang H, et al. Lactobacillus plantarum ameliorates colorectal cancer by ameliorating the intestinal barrier through the CLA-PPAR-\u03b3 axis. J Agric Food Chem. 2024;72(36):19766\u201385.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"4263_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41419-023-06371-1","volume":"15","author":"Y Yu","year":"2024","unstructured":"Yu Y, Farooq MS, Eberhart Meessen S, Jiang Y, Kato D, Zhan T, et al. Nuclear pore protein POM121 regulates subcellular localization and transcriptional activity of PPAR\u03b3. Cell Death Dis. 2024;15(1):7.","journal-title":"Cell Death Dis"},{"key":"4263_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116908","volume":"237","author":"IG Nicchio","year":"2025","unstructured":"Nicchio IG, Cirelli T, Quil L, Camilli AC, Scarel-Caminaga RM, Leite FRM. Understanding the peroxisome proliferator-activated receptor gamma (PPAR-\u03b3) role in periodontitis and diabetes mellitus: A molecular perspective. Biochem Pharmacol. 2025;237:116908.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"4263_CR45","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.7150\/thno.69054","volume":"12","author":"S Wang","year":"2022","unstructured":"Wang S, Lin Y, Gao L, Yang Z, Lin J, Ren S, et al. PPAR-\u03b3 integrates obesity and adipocyte clock through epigenetic regulation of Bmal1. Theranostics. 2022;12(4):1589\u2013606.","journal-title":"Theranostics"},{"issue":"11","key":"4263_CR46","doi-asserted-by":"publisher","first-page":"9190","DOI":"10.3390\/ijms24119190","volume":"24","author":"I Psilopatis","year":"2023","unstructured":"Psilopatis I, Vrettou K, Troungos C, Theocharis S. The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer. Int J Mol Sci. 2023;24(11):9190.","journal-title":"Int J Mol Sci"}],"updated-by":[{"DOI":"10.1186\/s12951-026-04684-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000}}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04263-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04263-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04263-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:02:19Z","timestamp":1783058539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04263-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4263"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04263-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12951-026-04684-9","URL":"https:\/\/doi.org\/10.1186\/s12951-026-04684-9","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the WMA Declaration on Animal Use in Biomedical Research and were approved by the Animal Ethics Committee of Nankai University Laboratory Animal Center (No. 2024-SYDWLL-000801).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}